Global Anticoagulants Market Outlook to 2020 – Demand for Patented NOACs with Prevalence of Cardiac Diseases to Drive Global Market” provides a comprehensive analysis of the anticoagulants market. The report includes the cumulative revenue generated by the market players from the sales of anticoagulants, including both generic and patented drugs at manufacturer’s price and market share contributed by the sales of heparin, NOACs, Vitamin K Antagonists, and Injectable Direct Inhibitors in the total anticoagulants market. Further, the market in the study is differentiated on the basis of route of administration into oral and injectable. The market is also segmented by four geographical regions across the globe – North America, Europe, Asia Pacific, and Rest of the World. Detailed snapshot on key regions of the Market which includes North America, Europe, and Asia Pacific is included in the report to elucidate facts about the market in detail. The study also highlights the detailed information about major drug manufacturers in the global anticoagulants market and their respective shares by revenue in 2015. Analysis on patented drugs available in the market, and their approval procedure, timeline, and expected expiries is provided in report to assist new entrants in understanding the market before investing in the market. Various marketing analysis factors such as trends and developments and Porter’s five forces analysis are also added in the study for clear understanding about the factors responsible for present scenario of the market. The future analysis of overall global anticoagulants market has also been discussed along with recommendations from analyst view.
Global Anticoagulants Market
Anticoagulants being the major part of the first line treatment of heart diseases including atrial fibrillation, deep vein thrombosis, pulmonary embolism, and stroke have been used extensively across the globe. Moreover, growing prevalence of coagulation disorders coupled with the aging population has increased the demand for anticoagulant drugs consequently leading to increased revenue generation. Launch of four patented drugs in the market in newly formed anticoagulants drug class, novel oral anticoagulants (NOACs) in between 2008 and 2014 has also resulted in high revenue generation for the total anticoagulants market as patented drugs are expensive in nature. Global anticoagulants market has been valued at USD ~ million in 2013 which increased to USD ~ million in 2015, exhibiting a CAGR of ~% in between 2013 and 2015.
Global Anticoagulants Market Segmentation
On the basis of type, heparin dominated the anticoagulants market with revenue share of ~% in 2015. Application of the heparin in wide therapeutic indications including venous thromboembolism, extracorporeal circuit procedure, and treatment of disseminated intravascular coagulation is the major factor which has led to the domination of heparin in the market. NOACs followed the heparin market in the global anticoagulants market with revenue share of ~% in 2015. The segment is also estimated as the fastest growing segment in the market. Flexibility to consume the drugs orally in comparison to injectables coupled with the presence of patented drugs in the market is the major factor which has driven the market for NOACs globally. Among the four patented drugs available in the NOAC category in the market, Bayer’s Xarelto has been observed to generate maximum sales providing company domination over other players.
By route of administration, injectable anticoagulants dominated the anticoagulants market with revenue share of ~% in 2015 owing to the availability of heparins and direct inhibitors in injectable state only. Heparins being oldest type of anticoagulants known are approved in all countries across the globe, which is one of the major factors driving the market for injectable anticoagulants. However, the segment is slowly losing revenue share owing to the increasing demand for oral anticoagulants due to ease of consumption and effective results.
By geographical regions, North America dominated the market with revenue share of ~% in 2015. High prevalence of coagulation disorders including atrial fibrillation, DVT and PE, presence of pharmaceutical giants, high awareness among people and economic stability to undergo expensive treatment options are the major factors which have driven the anticoagulants market in North America. Centers for Disease Control and Prevention estimated that approximately ~ to ~ million people in the US had atrial fibrillation in 2015 and with aging population, number is expected to increase. The statistics clearly advocates the high demand for anticoagulants in the region. Asia Pacific is estimated as the most opportunistic region in the market. High population in the country coupled with rising awareness and purchasing power of the people especially in India and China is assisting the region to grow at a rapid pace.
Bayer dominated the global anticoagulants market in 2015 with revenue share of ~% in 2015. The advantage of owning the oldest type of patented NOAC, Xarelto in the market resulting in associated trust factor with the drug is the major factor which has helped the company in gaining high revenue share in the market. Sanofi with its Lovenox or Clexane in LMWH category captures second position in the market with revenue share of ~% in 2015. High popularity of the drug with wide patient pool of almost ~ million patients in more than 100 countries is the major factor which has helped company in generating high revenue in the market.
Key Topics Covered in the Report:
Ankur Gupta, Head Marketing & Communications
X22Report Bubbles Are Popping, Prepare for Collapse - Episode 1261a
National Geographic Drops Crazy Bombshell That Just Might Prove the Book of Hosea Is Happening...
Google Seeking to Control Entire Internet and Execute a News Blackout - Something Huge Is Coming!
Tanks on Move Near Oroville Dam - Big Story Unfolding
Time Is Running Out Fast: Are You Ready for What's Coming? Why Isn't Anyone Talking About This?! (Videos) Mr Doom, Jason A
The Impossible Event that Changed the World - Everybody Needs to Be Talking About This - New Jason A Video
11 Facts That Prove That the U.S. Economy in 2017 Is in Far Worse Shape Than it Was in 2016
X22Report Event of All Events, the Day When the Lights Go Out - Episode 1261b
Mainstream Media Gets Caught in its Own Snare! Classic!
Pedogate: Former Trump Campaign Manager Judge Tim Nolan Indicted on Sexual Trafficking Charges (Video)
Could This Be the Root Cause of Inflammation and Many Modern Diseases?
US Pilot Ejects From Jet Approaching Carrier Headed for Korean Peninsula
This Doctor Delivers the Best Explanation and Treatment for Alzheimer’s
Car Dragged by Truck for Miles, Truck Driver Oblivious
York police say 104 men arrested as part of child sex trafficking probe
Berkeley Co. deputies release dash cam video in fatal motorcycle pursuit
This map shows what $100 is actually worth in your state
American Airlines flight attendant ‘whacks a mother in the head
TradCatKnight: Coronal Hole From Sun Could Put Power Grids In Danger Next Week – Produce Mass-Blackouts
James Perloff - 14 Reasons Why the Syria Missile Strike Was a Really Bad Idea
If Trump Does This, it's Game Over!
X22Report Bubbles Are Popping, Prepare for Collapse - Episode 1261a
Marine Le Pen and Emmanuel Macron Win in French Election_Tim Pool
Wrath of Trump: U.S. Forces Bomb the Sh*t Out of ISIS Again!
The 3 Best Major OOC Sports Moments of last 5 years for Wake Forest, Louisville, and NC State
Sunday Night Acoustic Guitar Masterpiece: Grayson Erhard, "Unspecified Bird Calls"
Embarrassing: Fake News Doesn’t Get More Obvious Than This!
Ron Paul Attacked by the CATO Institute - Claims He's Not a Libertarian
French Elections – Dollar index – Gold – Silver Trading